Novo Integrated Sciences, Inc. Unbilled Receivables, Current
Novo Integrated Sciences, Inc. had Unbilled Receivables, Current of $17.35 thousand as of 2024-08-31, per its 10-K filed 2024-12-18.
Financial Statements › Balance Sheet › Assets › Assets, Current › Receivables, Net, Current
us-gaap:UnbilledReceivablesCurrent · last filed 2024-12-18
- 2024-08-31: Unbilled Receivables, Current $17.35K.
- 2024-05-31: Unbilled Receivables, Current $49.27K.
- 2024-02-29: Unbilled Receivables, Current $66.54K.
- 2023-11-30: Unbilled Receivables, Current $78.51K.
| Period end | Unbilled Receivables, Current |
|---|---|
| 2024-08-31 | $17.35K 10-K · filed 2024-12-18 |
| 2024-05-31 | $49.27K 10-Q · filed 2024-07-19 |
| 2024-02-29 | $66.54K 10-Q · filed 2024-04-15 |
| 2023-11-30 | $78.51K 10-Q · filed 2024-01-22 |
| 2023-08-31 | $108.00K 10-K · filed 2024-12-18 |
| 2023-05-31 | $35.82K 10-Q · filed 2023-07-17 |
| 2023-02-28 | $52.65K 10-Q · filed 2023-05-26 |
| 2022-11-30 | $88.73K 10-Q · filed 2023-05-24 |
| 2022-08-31 | $180.26K 10-K · filed 2023-12-14 |
| 2022-05-31 | $132.43K 10-Q · filed 2022-07-14 |
| 2022-02-28 | $134.82K 10-Q · filed 2022-04-13 |
| 2021-11-30 | $143.66K 10-Q · filed 2022-01-18 |
| 2021-08-31 | $154.56K 10-K · filed 2023-04-03 |
| 2021-05-31 | $36.32K 10-Q · filed 2021-07-14 |
| 2021-02-28 | $179.71K 10-Q · filed 2021-04-14 |
| 2020-11-30 | $151.57K 10-Q · filed 2021-01-13 |
| 2020-08-31 | $301.94K 10-K · filed 2021-12-14 |
| 2020-05-31 | $148.93K 10-Q · filed 2020-07-14 |
| 2020-02-29 | $313.79K 10-Q · filed 2020-04-20 |
| 2019-11-30 | $327.87K 10-Q · filed 2020-01-13 |
| 2019-08-31 | $304.06K 10-K · filed 2020-12-09 |
| 2019-05-31 | $286.62K 10-Q · filed 2019-07-11 |
| 2019-02-28 | $242.36K 10-Q · filed 2019-04-11 |
| 2018-11-30 | $232.25K 10-Q · filed 2019-01-11 |
| 2018-08-31 | $237.89K 10-K · filed 2019-11-20 |
| 2017-08-31 | $242.03K 10-K · filed 2018-11-06 |